Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 1/2 1

Status

Completed 7Terminated 4Recruiting 4Unknown 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER_GOV 1OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4Head & Neck 1

Conditions

Neoplasms 473Carcinoma, Non-Small-Cell Lung 447Breast Neoplasms 331Neoplasm Metastasis 242Colorectal Neoplasms 214Melanoma 213Leukemia, Myeloid, Acute 191Multiple Myeloma 180Recurrence 169Ovarian Neoplasms 169Prostatic Neoplasms 163Lymphoma, Non-Hodgkin 148Lung Neoplasms 134Pancreatic Neoplasms 125Lymphoma 123Carcinoma, Renal Cell 112Squamous Cell Carcinoma of Head and Neck 110Leukemia, Lymphocytic, Chronic, B-Cell 110Stomach Neoplasms 92Carcinoma, Hepatocellular 89Lymphoma, Large B-Cell, Diffuse 88Leukemia 87Triple Negative Breast Neoplasms 86Lymphoma, Follicular 82Head and Neck Neoplasms 79Glioblastoma 74Myelodysplastic Syndromes 70Urinary Bladder Neoplasms 68Small Cell Lung Carcinoma 64Precursor Cell Lymphoblastic Leukemia-Lymphoma 55

Interventions

EPI-506 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × INDUSTRY × Prostatic Diseases × Clear all
NCT03490838 2025-05-13

PROter

Advanced Accelerator Applications

Phase 1 Terminated
27 enrolled
Genitourinary

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT04249947 2025-02-17

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Poseida Therapeutics, Inc.

Phase 1 Terminated
40 enrolled
GenitourinaryHead & Neck

Carcinoma, Adenoid Cystic, Genital Neoplasms, Male, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Salivary Gland Neoplasms, Urogenital Neoplasms, Carcinoma, Acinar Cell, Carcinoma, Mucoepidermoid, Prostatic Neoplasms, Castration-Resistant

NCT04575766 2023-08-09

A Study of FT-7051 in Men With MCRPC

Novo Nordisk A/S

Phase 1 Terminated
25 enrolled
Genitourinary

Urogenital Diseases, Prostatic Diseases, Prostatic Neoplasms

NCT02606123 2018-03-01

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

ESSA Pharmaceuticals

Phase 1/2 Terminated
28 enrolled
Genitourinary

Genital Diseases, Male, Genital Neoplasms, Male, Prostatic Diseases, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡